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Receptor mediated uptake of apo B and apo E rich lipoproteins by
glomerular epithelial cells. Various pathological disorders are accompa-
nied by the deposition of lipids into glomerular cells. To gain insight into
these disorders, it is essential to know if glomerular cells possess
lipoprotein receptors. We therefore characterized the activity of lipo-
protein receptors in cultured epithelial cells of the human glomerulus.
Podocytes were chosen as they are directly exposed to lipoproteins in
pathological states like in glomerular proteinuria (such as, nephrotic
syndrome). Isolated human glomeruli (purity >95%) were incubated in
buffered RPMI 1640 medium supplemented with 20% heat-inactivated
fetal bovine serum at 37°C and 5% CO2. Outgrowing cells were vimentin
and keratin positive. Monolayer cultures of human glomerular epithelial
cells upon incubation in lipoprotein deficient serum for 48 hours
expressed a receptor-dependent uptake of lipoproteins. These cells
showed about 10% of the maximal capacity for LDL uptake as
compared to fibroblasts; however, the Km values for binding, internal-
ization and degradation were similar in the cultures of glomerular
epithelial cells and fibroblasts. The Km values for degradation of LDL,
chylomicron remnants, /3-VLDL from cholesterol-fed rabbits and
VLDL from familial LCAT-deficiency patients were 14.2, 4.9, 2.9, 4.5
sg protein/mi medium, respectively, for glomerular epithelial cells. The
avid uptake of '251-labeled apo E-containing lipoproteins was further
substantiated by their poor displacement by a 25-fold excess of unla-
beled LDL and their ability to down regulate the apo B,E receptor
activity. LDL as well as /3-VLDL were able to suppress the incorpo-
ration of 14C acetate into sterols and to stimulate 3H-cholesterylester
formation. These experiments show that cultured glomerular epithelial
cells express lipoprotein receptor activity. Plasma concentrations of
apo E-containing lipoproteins are increased in certain renal diseases
(such as, nephrotic syndrome); these lipoproteins could be rapidly
removed by glomerular epithelial cells and lead to lipid deposition in
glomeruli.
Deposition of lipids in renal glomeruli may occur in advanced
glomeruiar lesions due to immunologic or metabolic insults [1].
Analogous to the role of lipids in atherosclerosis, the glomerular
lipid accumulation has been implicated in the progression of
glomerular sclerosis [2].
In minimal change glomerulopathy with focal and segmental
sclerosis—a disease encountered in young patients with ne-
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phrotic syndrome—foam cells can be observed in sclerotic
areas [3].
One of the most widely studied diseases of renal lipoidosis is
a rare genetic disorder of lipoprotein metabolism, "Familial
lecithin:cholesterol acyl transferase" (LCAT) deficiency. Pa-
tients with LCAT deficiency show an abnormal plasma lipopro-
tein profile. Many LCAT deficiency patients develop protein-
uria. In some of these patients renal biopsies have been
performed and accumulation of lipids in glomeruli and glomer-
uloscierosis have been observed [4]. Lipid droplets were found
in the endothelial, mesangial and visceral epithelial cells, as
well as in the subendothelial and subepithelial parts of the
glomerular basement membrane [5]. In addition, increased
concentrations of phospholipids and free cholesterol were mea-
sured in isolated glomeruli. It is thought that glomerular lipids
play an important pathogenic role in the glomerulosclerotic
process of familial LCAT deficiency patients [6].
To gain insight into the pathogenesis of glomerular lipoidosis
it is desirable to investigate the lipoprotein receptor activity of
human glomerular cells in culture. Mesangial cells exhibit
phagocytic functions and may thus be expected to take up
lipoproteins by a non-saturable, receptor independent mecha-
nism and may under pathological conditions accumulate lipids
like macrophages in atherosclerotic plaques [7, 81. However, it
has recently been reported that these cells take up lipoproteins
in a manner similar to smooth muscle cells by receptor medi-
ated pathway [9, 101. Visceral epithelial cells, also called
podocytes, are the major cell types of the glomerulus in terms of
volume [111. We therefore investigated the uptake of apo B-lOU
containing lipoproteins such as LDL and apo B, E containing
lipoproteins such as postprandial chylomicron remnants and
unusual VLDL particles found in the plasma of rabbits fed high
cholesterol diet, and VLDL from the plasma of a patient with
familial LCAT deficiency.
Our data show that human glomerular epithelial cells take up
apo B-lOU containing lipoprotein, that is, LDL as well as apo B,
E containing lipoproteins such as chylomicron remnants, /3-
VLDL from cholesterol-fed rabbits and VLDL from the plasma
of a familial LCAT-deficiency patient. However, the affinity for
uptake of apo B, E containing lipoproteins is much higher than
that for LDL. The receptor mediated uptake of lipoproteins
suppresses the cellular sterol synthesis and cholesterylester
formation.
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Methods
Biochemicals
All chemicals and biochemicais were obtained from Sigma
Chemie GmbH (Munchen, FRG), E. Merck GmbH (Darmstadt,
FRG) or Boehringer (Mannheim, FRG). Bovine and human
serum albumin, fatty acid free, were obtained from Behring
(Marburg, FRG); cell culture medium and fetal calf serum were
from Gibco Europe Ltd. (Eggenstein, FRG). Sterile cell culture
plastic and glassware were purchased from Becton Dickinson
(Heidelberg, FRG). '251-sodium iodide, 2-['4C] sodium acetate
and 9, l0-[3H] oleic acid were purchased from Amersham
Buchler GmbH & Co., KG (Braunschweig, FRG). The mouse
monoclonal vimentin antibody (V9) and mouse monoclonal
antibody against keratin intermediate filaments (LU 5) were
from Dr. M. Osborn, Max Planck Institute of Biophysical
Chemistry (Gottingen, FRG). Goat antimouse IgG was labeled
with fluorescein isothiocynate (FITC) purchased from Cappel
Chemical Laboratory (Cochraneville, Pennsylvania, USA).
Isolation of human glomeruli
Human glomeruli. Human kidneys were obtained from renal
carcinoma patients. Immediately after surgical removal, carci-
noma free parts of kidneys were excised and stored in sterile,
ice-cold calcium-free phosphate buffered saline, PBS (136.9 mri
NaCI, 2.68 mi KC1, 1.47 mri KH2PO4 and 10.44mM Na2HPO4,
pH 7.4). All subsequent steps were carried out in the same
buffer under sterile conditions. Cortices were freed from cap-
sule and medulla, minced to a fine paste and passed through a
stainless steel sieve (mesh size 250 jim). This was followed by
several washes on a metal sieve of pore size 106 jim. Glomeruli
retained on this sieve were collected in PBS, carefully pipetted
in and out for one to two minutes through a pasteur pipette and
centrifuged for five minutes at 120 g. The pelleted giomeruli
were resuspended in RPM! 1640, (14.1 mr'i Hepes, 23 mM
glutamine, pH 7.4) supplemented with 26 mg/liter bovine pan-
creas insulin, 100 mg/liter streptomycin, 100.000 U/liter penicil-
lin and 20% fetal calf serum.
Light and scanning electron microsocpy showed that pellets
were isolated, decapsulated glomeruli of 95% purity with an
intact layer of podocytes.
Cultured glomerular cells. Glomeruli suspended in supple-
mented RPMI 1640 medium were seeded at a density of
approximately 2000 glomeruli in 30 x 10 mm culture dishes and
incubated at 37°C in humidified 5% CO2. After about one week,
cells growing out of glomeruli adherent to culture dishes could
be observed, and thereafter the medium was changed at an
interval of two days. After about 28 days, primary cultures
outgrowing from glomerular cells were trypsinized and sepa-
rated from the glomeruli and glomerular debris by filtration
through a nylon sieve (75 jim pore size). The filtrate was
subcultured and monolayers were confluent within nine days.
Monolayer cultures in first passage were used throughout this
study.
Cultured human fibroblasts
Skin biopsies obtained from normal adult donors were cul-
tured in plastic dishes in Dulbecco's minimal essential medium
which contained 25 mM NaHCO3, 20 mii Hepes buffer, pH 7.4,
and 10% fetal calf serum. Culture medium was also supple-
mented with 100 mg streptomycinhliter and 100.000 U penicillin/
liter [12]. Outgrowing fibroblasts were maintained in a humidi-
fled incubator (5% CO2 at 37°C).
Isolation of lipoproteins
Blood from normal donors and a patient suffering from
familial LCAT deficiency was drawn into tubes containing
EDTA (1 mg/mI) after an overnight fast. After separation of
chylomicrons by centrifugation at 100,000 g (d < 1.006 gIml) for
40 minutes, the infranate was brought to d = 1.019 glml by
addition of solid NaC1 and centrifuged for 24 hours at 150,000 g
and 10°C [13]. The floating lipoproteins (VLDL + IDL) were
collected by tube slicing technique. The infranate was then
adjusted to d = 1.060 g/ml by addition of solid NaCI and
centrifuged at 150,000 g (24 hr at 10°C). The floating LDL was
collected by tube slicing technique.
The LCAT deficiency patient was a 42-year old female born
in Southern Germany. Both the clinical as well as biochemical
investigations established the diagnosis of familial LCAT defi-
ciency [141. After separation of chylomicrons by centrifugation
at 100,000 g (d < 1.006 gIml) for 40 minutes, infranate was
brought to d = 1.006 gIml by addition of solid NaCl and
centrifuged for 24 hours at 150,000 g at 10°C for isolation of
VLDL.
/3-VLDL from cholesterol-fed rabbits was isolated as de-
scribed elsewhere [15].
Chylomicron remnants were prepared from chylomicrons
that were obtained from two-hour postprandial plasma of nor-
mal human subjects. Chylomicrons were incubated with post-
heparin rat plasma (2 mg chylomicron cholesterol and 4.5 ml
post-heparin plasma in 0.1 M Tris HC1 buffer, pH 8.5, that
contained 5% albumin) for one to two hours at 37°C. The
remnants were then isolated by centrifugation at 100,000 g for
100 minutes at 10°C at a solvent density of 1.019 g/ml.
Lipoproteins were labeled with 125! by the iodine monochlo-
ride method as modified for lipoproteins [16]. All iodinated and
non-iodinated lipoproteins were sterilized by a passage through
a 0.45 jim millipore filter, kept sterile, tightly closed at 4°C and
used within one to two weeks.
Assay for binding, internalization and proteolytic degradation
of lipoproteins
Cultures of glomerular epithelial cells in first passage and
human skin fibroblasts in third to fifth passage were trypsinized
and seeded into 20 mm petri dishes. After seven days the
cultures were washed with Duibecco's phosphate buffer saline
(PBS buffer) and fresh medium that contained 10% lipoprotein
deficient serum (LDS, 4 mg protein/mi) was used instead of fetal
calf serum to induce maximal apo B, E receptor activity. After
a 48 hour incubation, monolayers were washed with PBS and
fresh LDS containing medium was added together with 125J.
labeled lipoproteins with or without a 25-fold excess of unla-
beled lipoproteins. The cultures were incubated for five hours at
37°C [17]. The medium was removed and the cells were placed
on ice. The culture dishes were then washed five times with a
cold buffer containing 0.15 M NaC1, 50 mvt Tris (pH 7.4) and 2
mg/mi bovine fatty acid free serum albumin as described by
Goldstein, Basu and Brown [181. Assays for binding, internal-
ization and degradation were performed by standard methods
S •e
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Fig. 1A. Primary culture of human
glomerular cells. Cells with epithelial
appearance have formed a confluent layer
around necrobiotic glomeruli (24th day of
culture, x 100). B. Cells growing out of a
glomerulus (asterisk) show rudimentary foot
processes (Transmission electron microscopy,
x 3629). C and D. Immunofluorescence of
human glomerular cells in primary subculture
(7th day after subculture); cells react with
antibodies to keratin (C) and vimentin (D).
[18]. The heparin releasable activity represents binding at 37°C.
After the release of cell surface bound activity by heparin,
monolayers were dissolved in 1 ml of 0.1 N NaOH and radio-
activity and protein was measured. The radioactivity in the
pellet was taken as a measure for internalization. Non-iodide
tricholoroacetic acid (TCA)-soluble radioactivity served as a
measure for lipoprotein degradation. Non-specific binding, in-
ternalization and degradation was defined as amount of the
lipoprotein taken up in the presence of 25-fold excess of
unlabeled ligand.
Measurement of cellular sterol synthesis and cholesterol
esterification
Cellular sterol synthesis was measured by the incorporation
of ['4C} acetate into sterols: Cultures of glomerular epithelial
cells were incubated with unlabeled lipoproteins (after 48 hr in
LDS) in 1 ml of fresh medium containing LDS. After six hours,
the medium was removed and fresh 1 ml of medium containing
0.8 /hCi of [14C] acetate and unlabeled carrier acetate (0.2
mo1/ml, specific activity 4 tCi/mol) was added to each dish
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and incubations continued for two hours at 37°C. The cells were
washed twice with PBS/BSA medium and three times with PBS
alone. They were dissolved in 2 ml of 0.1 mrvt NaOH, ultrason-
ified and a portion of it was removed for measurement of ['4C]
activity and protein [17—19].
Cell lysate (1 ml) was saponified by addition of 1 ml of 100%
ethanol and 0.2 ml of 90% KOH at 80°C, for three hours.
510 20 50
'251LDL, g protein/mi medium
Fig. 2. Concentration dependent uptake of 2251-LDL by monolayer
cultures of human skin fibroblasts and cultures of human glomerular
epithelial cells. Symbols are: (upper circles) fibroblasts; (lower
circles) glomerular cells. A. Receptor-specific heparin releasable
binding at 37°C. B. Receptor specific internalization at 37°C. C
Receptor specific degradation at 37°C. * All measurements were
carried out in triplicate and values are means SEM of three
experiments.
Non-saponifiable lipids were extracted into 2.5 ml of hexane.
The hexane layer was washed once with 2.5 ml of 0.1 m
sodium acetate. The hexane phase was collected, evaporated
and ['4C] activity was measured. Incorporation of [14C] acetate
into sterols is expressed in picomoles of acetate found in
non-saponifiable lipids.
Cellular cholesterol esterification: After a 48 hour incubation
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Fig. 3. Displacement of '251-LDL by increasing concentrations of
unlabeled LDL in human glomerular epithelial cells (10 pg '251-LDL
(= 100%). A. Displacement of bound '251-LDL. B. Displacement of
internalized '251-LDL. C. Displacement of degraded 1251-LDL. CAll
500 measurements were carried out in triplicate and values are means
SEM of three experiments.
Table 1. Km and maximal capacities for uptake of various
lipoproteins in glomerular epithelial cells
and LDS medium containing 1 pCi of 9, 10 (n)-[3H] oleic acid
bound to fatty acid free albumin in a molar ratio of 1:4 was
added to monolayer cultures (specific activity 20 p.Ci/prnol and
final [3H] oleate concentration of 50 nmol/ml). After two hours
incubation at 37°C [18—20], cultured cells were then washed as
before, scraped into plastic tubes with a rubber policeman and
pelleted by centrifugation. Water (0.4 ml) was added and pellets
homogenized by ultrasonification. An aliquot (0.2 ml) of ho-
mogenate was extracted with 25 volumes of chloroform and
methanol mixture (2:1), and the chloroform phase was washed
with 0.034% MgCl2 (0.2 mlJml of chloroform methanol extract).
The washed chloroform phase was dried under vacuum and
resuspended in 200 .t1 of chloroform and methanol mixture
(2:1). One hundred microliters of the chloroform and methanol
solution was chromatographed on silica gel thin layer plates
using a solvent system hexane : diethylether:acetic acid (83:16:1,
vollvollvol). Bands comigrating with cholesteryl oleate stan-
dard were scraped and [14CJ oleate incorporated in cholesteryl
ester quantitated. The water homogenate of cultures was used
for measurement of cellular protein as well as direct measure-
ment of [3H] activity. Cholesteryl oleate formed was expressed
as picomole cholesteryl oleate formed per mg cell protein.
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Lipoprotein
Km
pg protein!
ml medium
Maximal capacities
ng/mg protein per
5 hr
LDL
Surface bound 17.1 (21.7) 29.9 (471)
Internalized 21.7 (21.7) 209.2 (2306)
Degraded 14.2 (20.3) 971.6 (9331)
Chylomicron remnants
Cell associated 2.8 (12) 642.3 (6020)
Degraded 4.9 (8.8) 67.1 (536)
13-VLDL
Cell associated 7.3 (6.6) 798.4 (1845)
Degraded 2.9 (5.6) 376.4 (2238)
VLDL-LCAT
Cell associated 6.5 (11.2) 98.9 (1145)
Degraded 4.5 (13.4) 362.1 (4209)
The data for Scatchard plots are derived from Figures 2, 4, 5 and 6.
Values in brackets denote the data from cultures of human fibroblasts.
in DME medium containing LDS, the medium was removed
and replaced with fresh medium containing test lipoproteins and
incubated for six hours. After this incubation fresh 2 ml of DME
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Analytical techniques
The protein content of cell extracts and lipoproteins was
measured by the method of Lowry et al [21]. The concentration
of unesterified cholesterol, cholesteryl ester, phospholipids and
triglycerides was determined by standard enzyme kit methods
[22]. Lipoproteins were identified by lipoprotein electrophore-
sis (Lipidophor Technique, Immuno A.G., Vienna, Austria)
and LP-X by agar gel electrophoresis (Rapidophor Technique,
Immuno A.G.) and also by chemical and immunochemical
analyses [23]. The apolipoprotein composition of various lipo-
protein fractions was determined by SDS-PAGE on 4 to 30%
polyacrylamide slab gels after lipoproteins were delipidated
with ethanol-diethyl ether (3:1) [24]. For ultrastructural exam-
ination culture cells were fixed in 2% glutaraldehyde for two
hours, embedded in araldite and cut parallel to the bottom of
cultured dishes. Ultrathin sections were stained with uranyl
acetate and lead citrate and examined in a Zeiss EM 10 electron
microscope.
Characterization of cultured glomerular cells
Primary cultures and first subcultures of cells outgrowing of
human glomeruli were characterized as glomerular epithelial
cells by light and electron microscopy and immunological
reactions with antibodies to intermediate filaments. Glomerular
cells appeared as attached polygonal epithelial cells (Fig. 1A).
These cells showed a positive reaction for keratin (Fig. 1C) and
vimentin (Fig. 1D). Electron microscopic examination of cells
growing out of glomeruli revealed rudimentary foot process-like
projections which were in direct contact with visceral epithelial
cells (Fig. 1B).
Uptake of '251-LDL by kidney epithelial cells
To establish whether kidney epithelial cells take up LDL by
receptor mediated pathway, cultures of glomeruli were incu-
bated for 48 hours in a medium containing LDS to upregulate
the LDL receptor activity. After this incubation varying con-
centrations of 1251-LDL were added to cultures. Similar exper-
iments were also carried out on cultured fibroblasts for com-
parative purposes. '251-LDL was bound, internalized and
degraded by cultures of glomerular epithelial cells in a concen-
tration dependent manner and the process was saturable (Fig.
2). The specificity of 1251-LDL uptake was over 75%. Analysis
of the data according to the method of Scatchard showed the
following constants: The Km for binding, internalization and
degradation was 17.1 LgIml, 21.7 g/ml and 14.2 g/ml, respec-
tively. The maximal capacities were 29.9 ng/mg cell protein,
209.2 nglmg cell protein and 971.6 nglmg cell protein for
binding, internalization and degradation, respectively (Table 1).
These values for Km compare favorably with the values ob-
tained for binding, internalization and degradation in cultured
fibroblasts. However, the values for maximal capacities are
about 9% of that observed in cultures of skin fibroblasts. These
data show that glomerular epithelial cells specifically take up
LDL but with low capacity when compared to cultured fibro-
blasts. The specificity of uptake of 1251-LDL was confirmed by
displacement experiments. When glomerular epithelial cells
were incubated with 1251-LDL (10 g!ml) in the presence of
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Fig. 4A. Concentration dependent uptake of 1251-chylomicron remnant
uptake by monolayer cultures of human skin fibroblasts (•) and human
glomerular epithelial cells (A). As a measurement of uptake at 37°C,
'251-cell associated activity was determined. All measurements were
carried out in triplicate and values are means SEM of three experi-
ments. B. Displacement of '251-chylomicron remnants (2.5 gig) by
increasing concentrations of unlabeled chylomicron remnants in
cultures of human glomerular epithelial cells. As a measure of uptake
at 37°C, '251-cell associated activity was determined. All measure-
ments were carried out in triplicate and are average of two experi-
ments.
25
Unlabeled remnants, pg protein/mi
Fig. 5. Concentration dependent uptake of 125j 13-VLDL from cholesterol-fed rabbits by monolayer cultures of human skin fibroblasts (•) and
human glomerular epithelial cells (A). A. Receptor specific cell associated activity at 37°C. B. Specific degradation at 37°C. All measurements were
carried out in triplicate and are average of two experiments.
unlabeled LDL, 10-fold excess of unlabeled LDL suppressed
the degradation of 1251-LDL by about 76% (Fig. 3).
Uptake of chylomicron remnants
Apo E containing lipoproteins show high affinity towards the
classical apo B, B receptors in cultured fibroblasts. In order to
examine whether the glomerular epithelial cells also show such
a high affinity towards apo E rich lipoproteins, chylomicron
remnants obtained from postprandial human chylomicrons
were used. The chemical composition of these remnants was
63% triglycerides, 14% cholesterol (of which 3% was unesteri-
fled), 16% phospholipids and 7% protein. Analysis by electro-
phoresis (SDS-PAGE) on polyacrylamide gel in the presence of
sodium dodecyl sulphate showed the presence of apo B-48, apo
B-l00 and apo E. The 1251-labeled remnants were taken up in a
concentration dependent and saturable manner by glomerular
epithelial cells. As a measure of uptake, the cell associated
NaOH soluble activity was measured (Fig. 4A). The analysis of
data by Scatchard plot yielded the following constants: Km
values for cell associated activity were 2.8 sg/ml for glomerular
epithelial cells and 12 tg/ml for cultures of fibroblasts. Thus
glomerular epithelial cells and cultured skin fibroblasts show
qualitatively similar if not identical high affinity for chylomicron
remnant uptake. However, the maximal capacities for uptake
differ. Thus maximal capacity for cell associated activity in
glomerular epithelial cells was only about 12% of the value
obtained in cultured fibroblasts (Table 1). The specificity of
chylomicron remnant uptake by glomerular cells was confirmed
by displacement experiments. A 12-fold excess of unlabeled
chylomicron remnants inhibited the 125J chylomicron remnant
uptake by about 80% (Fig. 4B).
Uptake of $-VLDL from cholesterol fed rabbits and VLDL
from a patient with familial LCAT deficiency
The plasma of rabbits, which are fed high cholesterol diet,
accumulate cholesteryl ester rich VLDL particles which show
f3-mobility instead of pre--mobiity in agarose gel electropho-
resis. These lipoproteins are rich in apo B and are recognized by
LDL receptor in cultured fibroblasts and are taken up avidly
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Fig. 6. Concentration dependent uptake of '251-VLDL from a patient
with familial LCAT-deficiency by cultures of human glomerular epithe-
hal cells. As a measure of uptake receptor specific degradation (•) and
cell associated (A) activity at 37"C were determined. All measurements
were carried out in triplicate.
because of their apo E content. Therefore we studied the uptake
f 125J 13-VLDL to determine if the affinity of their uptake was
similar to that observed with LDL or chylomicron remnants.
The chemical composition of /3-VLDL from cholesterol fed
rabbits was 65% cholesterol (of which 16% was unesterified),
6.7% triglycerides, 20.3% phospholipids and 8% protein. SDS-
PAGE showed the presence of apo B-48, apo B-l00 and apo E
as major apolipoproteins.
Like LDL and chylomicron remnants, these particles were
taken up by specific, concentration dependent and saturable
and receptor dependent pathway (Fig. 5). The analysis of data
by Scatchard plot yielded Km values for cell associated activity
of about 7.3 g/ml and 6.6 jg/m1 for glomerular epithelial cells
and cultured fibroblasts, whereas Km values for degradation
were 2.9 g/ml and 5.6 tgIml, respectively. However, the
maximal capacities were lower (43% for cell associated activity
and 19% for degradation) in glomerular epithelial cells when
compared to cultured fibroblasts.
The VLDL from a patient with familial LCAT deficiency is an
abnormal lipoprotein with regard to its chemical composition
and apolipoprotein distribution, and therefore was also tested
for its uptake. The chemical composition of this abnormal
lipoprotein was 13% cholesterol (of which 2.4% was esterified),
Table 2. Ability of excess of unlabeled LDL to inhibit uptake of
various '251-labeledlipoproteins in cultures of glomerular epithelial
cells
% Inhibition of uptake
'251-lipoprotein
Uptake in the absence
of unlabeled LDL
in the presence of
excess of unlabeled
5 p.g protein/,nl ng/ml cell protein/5 hr LDL
LDL 213±24 89±1
Chylomicron remnants 460 21 21 5
(cell associated)
13-VLDL 270 19 22 5
VLDL-LCAT 150 20 38 14
After 48 hr in medium containing LDS, the monolayer cultures were
incubated in fresh medium containing 1251 lipoproteins in the presence
and absence of a 25-fold excess of unlabeled LDL. As measure of
uptake, 1251 lipoprotein degradation was measured, except for chylomi-
cron remnants where only cell associated activity was measured. The
incubations were carried out in triplicate, and the results are given as
mean SEM of three experiments.
Table 3. Down regulation of lipoprotein receptor activity by apo B
and apo B, E-containing lipoproteins in cultures of giomerular
epithelial cells
Unlabeled
Uptake of 1251 lipoproteins
nglmg cell protein/S hr
125j chylomicron
lipoprotein 125J LDL remnants
None 349.5 20.5 (0%) 603.3 36.7 (0%)
LDL 174.9 19.5 (50 5%) 404.3 23.9 (30 4%)
Chylomicron 32.1 8.6 (91 2%) 239.7 6.8 (60 1%)
remnants
/3-VLDL 92.0 7.1 (74 2%)
Monolayer cultures of glomerular epithelial cells were incubated for
48 hours in medium containing LDS to upregulate the LDL receptor
activity. One milliliter of fresh medium containing LDS and unlabeled
lipoproteins (10 g protein/mi) was added to the cultures. After 24 hours
incubation 10 sg of 125! LDL or chylomicron remnants were added.
Degradation of 125j LDLand cell associated activity of 1251 chylomicron
remnants served as measure of uptake. All incubations were carried out
in triplicate and results are mean SEM of 3 experiments. Numbers in
brackets indicate % inhibition.
60% triglycerides, 19.2% phospholipids and 7.7% protein. This
VLDL had apo B-48, apo B-lOO, apo E as its major lipoproteins
and traces of apo A-I. It was taken up by glomerular epithelial
cells in a specific concentration dependent and saturable man-
ner (Fig. 6). The Scatchard plot analysis of the data showed
that, like other apo E-containing lipoproteins, LCAT-VLDL
showed high affinity for glomerular cells.
The data with apo E-containing lipoproteins demonstrated
that glomerular epithelial cells express a higher affinity towards
these lipoproteins than LDL. Table 1 summarizes these data
obtained from Scatchard plots. This is further substantiated by
the data from displacement experiments of labeled LDL, f3-
VLDL, LCAT-VLDL and chylomicron remnants in the pres-
ence of 25-fold excess of unlabeled LDL. Excess of unlabeled
LDL displaced 1251-LDL by 89%, whereas labeled apo E-
containing lipoproteins were displaced poorly (Table 2).
Effect of prolonged exposure to unlabeled apo B and apo
B,E-containing lipoproteins on receptor activity
Next we examined the ability of unlabeled LDL chylomicron
remnants and /3-VLDL to down regulate the lipoprotein recep-
12 5 10 20
C25!LCATVLDL
pg protein/mi medium
Gröne et al: Lipoprotein receptors in human kidney 1457
Table 4. Effe
synthesis and fo
cts of various lipoproteins on suppression of sterol
rmation of cholesteryl esters in cultures of glomerular
epithelial cells
Lipoprotein
Cholesteryl ester
Sterol synthesis formation
LDS
LDL
I3-VLDL
HDL
1.642 0.261 (100%) 0.243 0.080
0.618 0.188 (37.6%) 2.981 0.250
0.651 0.262 (39.5%) 8.408 0.51
1.706 0.134 (103.9%) 0.298 0.03
Monolayer cultures of glomerular epithelial cells were incubated in
medium containing LDS for 48 hr. After this preincubation, 1 or 2 ml of
fresh medium that contained lipoproteins (20 ag protein/mi) were added
to the cultures. Values of sterol synthesis are given as nmol '4C
incorporation in sterols/mg cell proteinf2 hr. Cholesterol esterification is
given as nmol 3H-oleate formed/mg cell protein/2 hr. All incubations
were carried out in triplicate, and results are given as mean SD of
three experiments.
tor activity in cultured human glomerular epithelial cells. After
48 hours in lipoprotein deficient serum (LDS) to upregulate
their LDL receptor activity, cultures were incubated for 24
hours with 10 jg protein/mi of unlabeled lipoproteins. After
washing the monolayer cultures, 15 g of 125! LDL or 125J
chylomicron remnants were added and incubations carried out
for five hours. Data in Table 3 show unlabeled chylomicron
remnants and /3-VLDL inhibited the uptake of 1251 LDL by 91
and 74%, respectively. This inhibition was much stronger than
by LDL. Using 125J chylomicron remnants as ligand for the
receptor showed that unlabeled LDL decreased the uptake of
chylomicron remnants by only 30%. Thus apo B,E-containing
lipoproteins were very effective in down regulating the apo B ,E
receptor activity in glomerular epithelial cells.
Effect of various lipoproteins on cellular sterol synthesis and
cholesterol esterfication in glomerular epithelial cells
Incorporation of [14C1 acetate into sterols is a measure of
cholesterol synthesis in a variety of cultured cells. To determine
whether lipoproteins that were taken up by giomerular cells
could regulate cholesterol synthesis, we incubated cultures of
glomerular epithelial cells in medium containing LDS to upreg-
ulate their lipoprotein receptor activity. After 48 hours cells
were incubated with LDL, /3-VLDL and normal HDL for five
hours (Table 4). In the absence of lipoproteins, high sterol
synthesis rates were noted. The presence of either LDL or
/3-VLDL at a lipoprotein concentration of 20 g protein/mi
inhibited sterol synthesis by about 60%. HDL from normal
plasma was ineffective in suppressing cholesterol synthesis in
cultured glomerular epithelial cells.
Measurement of [3H} oleate incorporation into cholesteryl
ester after incubation with various lipoproteins is a measure of
activation of acyl:cholesterol-acyltransferase (ACAT). It also
serves as a measure of effective cellular uptake of lipoproteins.
Glomerular epithelial cells were therefore incubated with vari-
ous lipoproteins and [3HJ cholesteryl oleate formation was
measured. Both LDL and f3-VLDL enhanced cholesteryl ester
formation whereas HDL was ineffective. The higher values of
cholesteryl ester formation with /3-VLDL are due to the higher
cholesterollprotein ratio in /3-VLDL as compared to LDL.
Discussion
Pathogenetic factors involved in glomerular sclerosis which
lead to progression of renal disease are still insufficiently
elucidated. Among various factors such as high protein diet,
impaired coagulative processes, increased glomerular intracap-
illary pressure, the plasma lipoprotein pattern and ultimately
the deposition of lipids in glomeruli, have been suggested to
contribute to sclerosis of glomerular capillary tufts [1, 2, 25—27].
Several observations in experimental animals and microscopic
examination of human renal biopsies lend support to the con-
cept of involvement of lipids in glomerular sclerosis [27]. Foam
cells and lipid deposits have been observed in renal tissue in
rats with puromycin aminonucleoside nephrosis. Histochemical
analyses show that cholesterol and phospholipids constitute the
bulk of these lipid deposits [28]. Also in human glomerular
disease renal lipoidosis can be observed [29]. Patients with
nephrotic syndrome can accumulate lipids in glomeruli and the
renal interstitium [3d. In the plasma of these patients VLDL and
chylomicron remnants accumulate. Further, these lipoproteins
show an abnormal lipid-protein composition [30]. Whether
normal as well as abnormal lipoproteins are taken up by
glomerular cells by a receptor mediated or receptor indepen-
dent pathway remained still unclear.
We therefore investigated the uptake of apo B- 100 and apo
E-rich lipoproteins in visceral epithelial cells cultured from
human glomeruli. These cells synthesize basement membrane
components and are involved in the genesis of sclerotic foci;
they have characteristic features that may be relevant in disease
states but not under normal conditions [31, 32]. This cell type
has been shown to accumulate lipids in glomerular disease. In
healthy kidneys visceral epithelial cells rest on the semiperme-
able glomerular basement membrane and are surrounded by
plasma ultrafiltrate devoid of lipoproteins. In glomerular pro-
teinuric states, high molecular weight proteins as well as
lipoproteins are filtered and can thus directly interact with
visceral epithelial cells.
In the present study, visceral epithelial cells showed receptor
mediated binding, internalization, and degradation of 125I-LDL.
This uptake was specific and could be displaced by increasing
concentrations of unlabeled LDL. Analyses of the data by
Scatchard plot revealed that maximum capacity for uptake
(binding, internalization and degradation) was only about 10%
of that noted in cultured fibroblasts. However, the Km values
for uptake were comparable in cultures of epithelial cells and
fibroblasts. Thus, glomerular epithelial cells take up LDL via a
receptor mediated pathway.
In various renal diseases apo E containing triglyceride-rich
lipoproteins, such as VLDL, /3-VLDL and chylomicron rem-
nant particles, accumulate in the plasma of these patients [30].
Apo E has been reported to be a ligand for their cellular uptake
[33]. We next examined the uptake of chylomicron remnants by
glomerular epithelial cells. These remnant particles show high
affinity binding in hepatic as well as peripheral cells [33, 34].
Cultured glomerular epithelial cells expressed high affinity but
low maximal capacity for uptake of chylomicron remnants. As
in the case of LDL, the Km values for uptake were similar to
those obtained in cultured fibroblasts. Cholesteryl ester-rich
VLDL (3-VLDL) which circulate in the plasma of cholesterol-
fed rabbits are also rich in apo E and utilize apo E as a ligand for
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their binding. Like chylomicron remnants, these lipoprotein
particles were also taken up with high affinity by cultured
glomerular epithelial cells.
One of the lipoprotein metabolic disorders which leads to
deposition of lipids in renal tissue is the familial LCAT defi-
ciency [4, 5]. The plasma lipoprotein pattern and as well as
lipid-protein composition of plasma lipoproteins is abnormal in
these patients. Most of these abnormal lipoproteins are thought
to originate from surface components of chylomicrons and are
apo E rich [34]. We next examined the uptake of VLDL from
LCAT deficiency patients. VLDL obtained from plasma of
normal fasting donors is a poor ligand for apo B ,E receptors in
cultured fibroblasts. However, VLDL with abnormal lipid
composition from a LCAT deficiency patient was taken up by
receptor mediated pathway.
The uptake of lipoproteins by receptor mediated pathway
leads to suppression of intracellular sterol synthesis and en-
hanced cholesteryl ester formation [19]. Glomerular epithelial
cells in cultures showed both the suppression of [14C} incorpo-
ration into sterols and increased formation of cholesteryl esters.
Thus, the data obtained on the uptake of radioiodinated lipo-
proteins and the metabolic effects of cholesterol delivered by
lipoproteins to these cells suggest that glomerular epithelial
cells are capable of receptor-mediated lipoprotein uptake.
The high affinity for the uptake of apo E containing lipopro-
teins by glomerular epithelial cells may have clinical signifi-
cance, since in kidney diseases accumulation of these lipopro-
teins may be pronounced. In nephrosis in man, apo E-rich
VLDL and their remnants show increased content of choles-
terol and triglycerides. These lipoproteins could be taken up by
a receptor mediated pathway into glomerular visceral epithelia.
In glomerular proteinuric states the avid uptake of apo E-
containing lipoproteins could then lead to accumulation of lipids
in visceral epithelia. Intracellular lipid deposition may further
be pronounced by a significant reduction in plasma LCAT
activity in nephrosis [35]. In fact, a recent case report shows
that apo B- and apo E-containing lipoproteins with 13-electro-
phoretic mobility accumulate in glomeruli and may thus con-
tribute to sclerosis in nephrotic syndrome [361. Although the
present study does not provide conclusive data on the role of
plasma lipoproteins in intracellular lipid accumulation in gb-
meruli, it attempts to conceptualize the mechanisms of lipid
deposition in visceral epithelium, one of the three major gb-
merular cell types. Similar mechanisms of receptor mediated
lipoprotein uptake may apply to endothelium and to mesangial
cells. Recent preliminary reports on rat and human mesangial
cells support this concept [9, 10].
In conclusion, our data show that gbomerular visceral epithe-
hal cells in cultures can take up normal lipoproteins as well as
apo E-rich abnormal lipoproteins via a receptor mediated and
not by a scavanger, that is, receptor independent, non-saturable
pathway. The affinity for the uptake of apo E-containing lipo-
proteins is high and comparable to data of these lipoproteins in
cultured fibroblasts. Apo B-rich lipoproteins accumulate in
plasma in nephrotic syndrome, which results in the exposure of
visceral epithelial cells to relatively high concentrations of these
lipoproteins. Avid uptake of apo B-containing lipoproteins
could contribute to glomerular lipid accumulation and sclerosis.
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